A CD8 T-Cell Epitope Variant Enhances Immune Targeting to a Recombinant Picornavirus Vaccine Antigen

Viral Immunology , Vol. 0, No. 0.
Source: Viral Immunology - Category: Allergy & Immunology Tags: article Source Type: research

Related Links:

Date: Friday, 02 28, 2020; Speaker: Anna P. Durbin, Professor, Johns Hopkins University; Building: Building 40; CR1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Tuesday, 05 12, 2020; Speaker: Hans Langedijk; Building: Building 40; CR1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Tuesday, 05 26, 2020; Speaker: Peter Palese, Ph.D. , Professor, Ichan School of Medicine at Mount Sinai; Building: Building 40; CR1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Tuesday, 06 02, 2020; Speaker: Andrea L. Cox, M.D., Ph.D., Professor, Johns Hopkins Medicine; Building: Building 40; CR1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Tuesday, 10 27, 2020; Speaker: Erol Fikrig, M.D., Professor, Yale School of Medicine; Building: Building 40; CR1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Friday, 01 31, 2020; Speaker: Mattia Bonsignori, M.D. , Associate Professor, Duke Human Vaccine Institute, Duke University Medical Center; Building 33; Room 1N09
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Tuesday, 02 11, 2020; Speaker: Tony Moody, M.D., Associate Professor of Pediatrics, Duke Human Vaccine Institute; Building: Building 40; CR1201/1203
Source: NIH Calendar of Events - Category: American Health Source Type: events
In this report, we present a case of ADEM associated with optic neuritis presenting alongside two potential triggering factors: chikungunya virus infection and yellow fever immunization.
Source: Revista da Sociedade Brasileira de Medicina Tropical - Category: Tropical Medicine Source Type: research
Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by recurrent bacterial infections and defined by reduced levels of IgG, IgA, and/or IgM, insufficient response to polysaccharide vaccination, and an abnormal B-cell immunophenotype with a significantly reduced fraction of isotype-switched memory B cells. In addition to this infectious phenotype, at least one third of the patients experience autoimmune, autoinflammatory, granulomatous, and/or malignant complications. The very heterogeneous presentation strongly suggests a collection of different disease entities with somewhat different patho...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Johnson &Johnson's chief scientist told CNBC that the company started developing a shot from scratch last week, and that he is 'pretty confident' that it will work, despite the long vaccine pipeline.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Allergy & Immunology | Vaccines